DaVita ROE 2006-2018 | DVA

Current and historical return on equity (ROE) values for DaVita (DVA) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. DaVita ROE for the three months ending September 30, 2018 was 13.87%.
DaVita ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $0.61B $4.03B 13.46%
2018-06-30 $0.54B $4.49B 11.19%
2018-03-31 $0.40B $4.78B 7.94%
2017-12-31 $0.66B $4.89B 12.98%
2017-09-30 $0.52B $4.97B 10.16%
2017-06-30 $1.30B $5.27B 25.34%
2017-03-31 $1.23B $5.34B 24.27%
2016-12-31 $0.88B $4.85B 17.71%
2016-09-30 $0.72B $5.12B 14.24%
2016-06-30 $0.36B $4.96B 7.14%
2016-03-31 $0.48B $4.92B 9.29%
2015-12-31 $0.27B $5.08B 5.17%
2015-09-30 $0.48B $5.19B 9.17%
2015-06-30 $0.45B $5.35B 8.58%
2015-03-31 $0.43B $5.17B 8.31%
2014-12-31 $0.72B $5.36B 14.24%
2014-09-30 $0.73B $5.15B 14.87%
2014-06-30 $0.68B $4.96B 14.44%
2014-03-31 $0.79B $4.84B 17.31%
2013-12-31 $0.63B $4.61B 14.65%
2013-09-30 $0.58B $4.44B 13.91%
2013-06-30 $0.59B $4.28B 15.78%
2013-03-31 $0.43B $3.96B 13.06%
2012-12-31 $0.54B $3.92B 18.65%
2012-09-30 $0.53B $2.67B 21.45%
2012-06-30 $0.52B $2.51B 22.38%
2012-03-31 $0.52B $2.40B 24.05%
2011-12-31 $0.48B $2.27B 22.67%
2011-09-30 $0.40B $2.08B 19.46%
2011-06-30 $0.38B $1.95B 18.03%
2011-03-31 $0.39B $2.14B 17.56%
2010-12-31 $0.41B $2.04B 17.82%
2010-09-30 $0.45B $2.38B 19.29%
2010-06-30 $0.44B $2.36B 19.45%
2010-03-31 $0.44B $2.32B 20.03%
2009-12-31 $0.42B $2.19B 20.36%
2009-09-30 $0.41B $2.14B 20.69%
2009-06-30 $0.39B $2.06B 20.43%
2009-03-31 $0.38B $1.92B 20.60%
2008-12-31 $0.37B $1.83B 20.46%
2008-09-30 $0.36B $1.91B 20.06%
2008-06-30 $0.36B $1.78B 20.87%
2008-03-31 $0.39B $1.80B 23.55%
2007-12-31 $0.38B $1.73B 24.59%
2007-09-30 $0.37B $1.63B 25.84%
2007-06-30 $0.37B $1.50B 28.28%
2007-03-31 $0.31B $1.35B 25.80%
2006-12-31 $0.29B $1.25B 26.28%
2006-09-30 $0.28B $1.15B 27.87%
2006-06-30 $0.24B $1.04B 26.34%
2006-03-31 $0.23B $0.96B 27.98%
2005-12-31 $0.23B $0.85B 31.14%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $10.682B $10.877B
DaVita Inc. is the parent company of DaVita Kidney Care and HealthCare Partners. DaVita Kidney Care is a provider of kidney care, delivering dialysis services for chronic kidney failure and end stage renal disease primarily in the United States. HealthCare Partners manages and operates medical groups and affiliated physician networks primarily in California, Nevada, New Mexico, Florida, Colorado and Washington. DaVita Inc., formerly known as DaVita HealthCare Partners Inc., is headquartered in Denver, Colorado.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $12.887B 14.96
Elanco Animal Health (ELAN) United States $12.435B 0.00
Encompass Health (EHC) United States $7.065B 20.23
Chemed (CHE) United States $4.918B 27.04
Amedisys (AMED) United States $3.734B 35.49
LHC Group (LHCG) United States $2.922B 30.63
U.S Physical Therapy (USPH) United States $1.460B 47.54
Addus HomeCare (ADUS) United States $0.894B 42.15
Hanger (HNGR) United States $0.689B 6.95
RadNet (RDNT) United States $0.636B 40.69
American Renal Associates Holdings (ARA) United States $0.506B 22.88
BioScrip (BIOS) United States $0.405B 0.00
Quorum Health (QHC) United States $0.154B 0.00
Catasys (CATS) United States $0.150B 0.00
Psychemedics (PMD) United States $0.101B 20.53
AAC Holdings (AAC) United States $0.057B 9.71
Daxor (DXR) United States $0.028B 0.00
Helios And Matheson Analytics Inc (HMNY) United States $0.011B 0.00